Dr. Ailis Tweed-Kent is the CEO and Founder of Cocoon Biotech. With her education in medicine at Harvard Medical School (HMS) and residency in internal medicine at Massachusetts General Hospital (MGH), Ailis has first-hand knowledge of the burden of disease. Prior to Cocoon, she worked on the design, development, and delivery of diagnostic technologies for global health collaborating with organizations such as PEPFAR/Office of U.S. Global AIDS Coordinator, London School of Hygiene & Tropical Medicine, and the Global Health Delivery Project. She brings a multidisciplinary approach with a B.S. in Chemical Engineering from the University of Notre Dame. She was recently named to the Boston Business Journal’s 2017 Women to Watch in Science and Technology as well as the Boston MedTech’s 40 Under 40 Healthcare Innovators.